PresVu Eye Drops: ENTOD’s Revolutionary Treatment for Presbyopia Launches in Mumbai

In a game-changing step, ENTOD Pharmaceuticals has launched PresVu, an amazing eye drop set to revolutionize life for those suffering from blurry vision due to presbyopia This new treatment is a possible alternative to traditional reading glasses, tackling a common age-related issue affecting millions around the globe. The release of PresVu in Mumbai is a big moment in eye care, potentially altering how folks deal with their everyday visual struggles.

The arrival of PresVu has sparked excitement among doctors and potential users alike. This innovative eye drop has gone through strict clinical tests to ensure it’s safe and effective. In this article, we’ll dive into the science behind PresVu, its approval journey, & its likely market impact. We’ll also hear from the CEO of ENTOD Pharmaceuticals about the company’s vision for this groundbreaking product and its availability for those needing clearer sight.

Revolutionary Treatment for Presbyopia

What is Presbyopia?

Presbyopia is a vision problem that usually starts hitting people in their early to mid-40s. It happens when the eye’s natural lens slowly loses flexibility, making it tough to focus on close objects. Between 1.09 to 1.8 billion people worldwide face this common condition. As time goes by, the lens gets stiffer and less able to change shape, making it hard to see things up close.

How PresVu Works

PresVu, created by ENTOD Pharmaceuticals, is an incredible eye drop designed to tackle presbyopia. It works by temporarily boosting the flexibility of the eye’s lens. When applied, the eye drop stimulates muscles around the lens, helping it reshape and focus better on nearby objects. This improved focusing means people with presbyopia can see clearly up close without needing reading glasses all the time.

The drops start working within 15 minutes of application, with full benefits becoming visible after 15 days of use. Designed for daily use, PresVu’s effects last several hours. If needed, another drop can be used three to six hours later for up to three more hours of clear vision.

Advantages over Traditional Methods

PresVu has several perks compared to traditional ways of treating presbyopia:

Non-invasive alternative: Unlike surgeries or lens implants, PresVu offers a non-invasive option.

Convenience: No more dealing with cumbersome reading glasses.

Quick onset: You can notice effects within 10 to 15 minutes.

Affordability: One vial lasts about a month & sells for ₹345.

Additional benefits: It not only reduces reliance on glasses but also helps lubricate eyes.

It’s crucial that PresVu is used only with a prescription from an ophthalmologist. While it promises great results, patients should consult their eye care provider about whether it suits their needs.

Clinical Trials and Approval Process

Phase 3 Trials in India

ENTOD Pharmaceuticals ran extensive phase 3 trials for PresVu across India. These trials involved 250 patients at 10 sites, thoroughly assessing the drug’s effectiveness and safety. Results showed that PresVu works best for folks aged 40 to 55 years with mild-to-intermediate presbyopia, providing temporary vision correction.

DCGI Approval

After passing clinical trials with flying colors, ENTOD got final approval from India’s Drug Controller General (DCGI) on September 3rd for PresVu—a big milestone in treating presbyopia in India. This approval was backed by recommendations from the Central Drugs Standard Control Organisation’s (CDSCO) Subject Expert Committee.

Comparison with US FDA Approval

Interestingly enough, the US Food and Drug Administration (FDA) had already approved similar eye drops in 2021 for presbyopia treatment. This approval helped pave the way for such treatments globally. The rigorous review process in both countries involves scrutinizing clinical trial data & risk management plans but often succeeds at setting gold standards worldwide.

Market Impact and Availability

Launch Timeline

ENTOD plans to bring PresVu eye drops to India’s market starting early October post-DCGI approval received on September 3rd following SEC’s recommendation—marking another important achievement in presbyopia treatment here.

Pricing Strategy

With competitive pricing set at ₹345 per vial lasting about one month—PresVu aims at wide accessibility potentially disrupting traditional reading glasses market aligning affordability towards mass adoption seeking alternatives beyond eyewear!

Target Demographics

Specifically tailored for individuals over 40 aiming reduced reliance upon reading glasses—optimal results observed among ages spanning between mild-moderate cases averaging around affected population globally!

CEO Nikkhil K Masurkar heralded as revolutionary disruptor within domestic arenas envisioning extending reach towards emerging markets extending into Africa & Southeast Asia emphasizing swift action onset within mere moments post-application enhancing extended usability assured long-term uninterrupted appearances ensuring seamless transition periods received upon consistent reliable performance metrics delivered seamlessly integrating advanced dynamic buffer technology uniquely adapted ensuring safety paramount considerations emphasized continuities empowering user experience comprehensively effectively minimizing surgical intervention dependencies traditionally encountered aforethought typically prevailing otherwise preexisting scenarios!

Users advised daily administration ideally under professional supervision reiterating cautionary advisement supplemental instances supplementable reiterated explicitly underscoring vitally prescription-oriented adherence deterministically outlined overall perspectives considered conclusively culminated!

Summery

PresVu is a brand-new eye drop solution for presbyopia aiming at reducing dependency on reading glasses priced affordably ₹345 per vial targeting individuals primarily over age forty showcasing rapid-action properties employing advanced adaptive technologies designed ensuring consistent reliability complying imperative prescription mandates professionally managed expected receive assurances derived comprehensively evaluated clinical insights fundamentally clarified collaboratively structured discourses effectively consolidating emergent vistas prognosticative prospects envisioned innovatively traversed coherently encapsulated!

You can read more about this revolutionary eye drop here

I you want to know how weight lose drug helps anti aging then click here